Condition
Transplants and Implants
Total Trials
6
Recruiting
0
Active
0
Completed
1
Success Rate
33.3%-53% vs avg
Key Insights
Highlights
Success Rate
33% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 55/100
Termination Rate
33.3%
2 terminated out of 6 trials
Success Rate
33.3%
-53.2% vs benchmark
Late-Stage Pipeline
50%
3 trials in Phase 3/4
Results Transparency
300%
3 of 1 completed with results
Key Signals
3 with results33% success
Data Visualizations
Phase Distribution
6Total
Not Applicable (1)
P 1 (2)
P 4 (3)
Trial Status
Unknown3
Terminated2
Completed1
Trial Success Rate
33.3%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT02442648Phase 1UnknownPrimary
B-Cell Targeted Carfilzomib Desensitization
NCT02522572Phase 1UnknownPrimary
Quantitating the Impact of Plerixafor
NCT00522548Phase 4TerminatedPrimary
Myfortic or CellCept Gastrointestinal Effects in African American Kidney Recipients
NCT00596947Phase 4TerminatedPrimary
Prednisone Withdrawal Versus Prednisone Maintenance After Kidney Transplant
NCT00771745Phase 4Completed
Prospective Pilot Study of Pre-Transplant Thymoglobulin Administration in Living Donor Renal Transplant Recipients
NCT01800929Not ApplicableUnknownPrimary
Evaluation of Performance and Usability of N6 in the Paediatric Population
Showing all 6 trials